Clinical Cancer Research
Our ambition is to establish a new norm in clinical cancer research, where patients are treated as partners, from the creation of research questions to the dissemination of results.
The importance and merit of patient involvement in research are widely acknowledged. When patients are involved, everyone benefits, because it ensures clinical and medical research work is performed more effectively and advances the delivery of what patients really need. This can only be achieved based on the collaborative identification and understanding of patients’ unmet needs. Receiving patient input throughout the design, implementation, and evaluation of clinical trials helps improve the discovery, development, and evaluation of new treatments.
Our funding approach is based on the following main principles :
Patient Centricity: We only support research designed according to our principles of patient involvement and bringing new ways to improve patients’ quality of life during their cancer treatment journey.
Short time frames, maximum impact: We fund interventional clinical trials that would not be funded by commercial organizations (Pharma/Biotech/Start up). Research projects should demonstrate patient impact within 3 to 5 years and start within 6 months upon official award notification.
Strategic Focus Areas: Designed together with an international expert group, our strategic focus areas form the core of our philanthropic funding approach.
Partnerships to maximize reach: We partner with other funding organizations to leverage resources and accelerate the improvement of patient treatment options and quality of life everywhere. We expect applicants to submit a co-funding plan describing their proportion secured support or a strong fundraising plan.
Improved Patient Outcomes
This overarching Focus Area supports research advancing therapeutic approaches that produce the best possible outcome with the least toxicity possible. The focus area also includes effective interventions that support symptom management during and after treatment.
Science of Early Detection and Intervention
This Focus Area supports novel strategies for high impact clinical research in prevention, early detection, and interception of precursors or early cancer.
Advancing Cancer Research in Underserved Areas
There is a global need for quality research in underserved areas. RTFCCR is piloting a patient-centered clinical cancer research grant-making program for which we will launch a call for proposals in the second half of 2023.
We accept Letters of Intent (LOIs) all year round with cutoff deadlines for internal assessment three times per year. Once you have submitted your LOI, you will receive further information regarding timing and next steps.
Pre-application grants provide gap funding to support patient experts’ helping to develop grant applications/ protocols.
Chronic Cancer Pain Research
This Request for Proposals focuses on interventions for the prevention and/or treatment of cancer-related chronic pain.
Patient Art Exhibition
What does ‘quality of life’ mean to you?
The Rising Tide Foundation has launched an international Patient Arts for Health – Global Exhibition to collect and curate art offering new insights on what quality of life means to people with cancer and their families through their art.